Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VCEL
VCEL logo

VCEL News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VCEL News

Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine

May 22 2026Globenewswire

Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine

May 22 2026Newsfilter

Vericel Corporation Reports Record Q1 2026 Earnings with Increased Guidance

May 08 2026seekingalpha

Vericel Q1 Earnings Beat Expectations with Strong Revenue Growth

May 07 2026seekingalpha

Vericel Scheduled to Announce Q1 Earnings on May 7

May 06 2026seekingalpha

Cell Therapy Market Set to Nearly Double by 2035

Apr 06 2026Newsfilter

Vericel Secures $197M Contract with U.S. BARDA

Apr 02 2026seekingalpha

Vericel Secures $197 Million BARDA Contract

Apr 02 2026Newsfilter

VCEL Events

05/07 09:30
Company Reaffirms FY26 Gross Margin Guidance of Approximately 75%
Consensus $323.43M. The company also reaffirmed its FY26 profitability guidance of a gross margin of approximately 75% and an adjusted EBITDA margin of approximately 27%.
05/07 09:30
Company Reports Q1 Revenue of $68.4M
Reports Q1 revenue $68.4M, consensus $63.62M. Reports Q1 MACI revenue $56.4M, up from $46.3M last year. Reports Q1 burn care revenue up 91% vs. last year. "The Company delivered outstanding financial and business results in the first quarter, as we generated strong revenue and profit growth and achieved several key business objectives," said CEO Nick Colangelo.

VCEL Monitor News

Vericel Corp stock declines amid market gains

Mar 25 2026

VCEL Earnings Analysis

No Data

No Data

People Also Watch